Table 1 Population characteristics according to COPD clinical control criteria
From: Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Whole sample (n = 4801) | Patients with controlled COPD (n = 1322) | Patients with uncontrolled COPD (n = 3479) | p-valuea | |
|---|---|---|---|---|
Gender, n (%) | ||||
Male | 3947 (82.2) | 1103 (83.4) | 2844 (81.7) | 0.1722 |
Female | 854 (17.8) | 219 (16.6) | 635 (18.3) | |
Age, years | ||||
Median (P25; P75) | 70.0 (63.0; 76.0) | 69.0 (63.0; 75.0) | 70.0 (63.0; 77.0) | < 0.0001 |
Active smoking, n (%) | ||||
Yes | 1168 (24.3) | 333 (25.2) | 835 (24.0) | 0.3915 |
No b | 3633 (75.7) | 989 (74.8) | 2644 (76.0) | |
Number of packs-year, nc | ||||
Median (P25; P75) | 45.0 (33.0; 60.0) | 45.0 (35.0; 60.0) | 45.0 (32.3; 60.0) | 0.4344 |
Level of care, n (%)d | ||||
Primary health care | 337 (7.1) | 57 (4.4) | 280 (8.1) | < 0.0001 |
Specialists | 4426 (92.9) | 1251 (95.6) | 3175 (91.9) | |
Degree of physical activity (IPAQ), n (%)e | ||||
High | 738 (16.5) | 316 (26.0) | 422 (12.9) | < 0.0001 |
Moderate | 1937 (43.2) | 626 (51.4) | 1311 (40.1) | |
Low or inactive | 1811 (40.4) | 275 (22.6) | 1536 (47.0) | |
Post-bronchodilator FEV1% | ||||
Median (P25; P75) | 41.0 (33.0; 46.0) | 42.4 (35.2; 47.0) | 40.0 (32.0; 46.0) | < 0.0001 |
Degree of treatment adherence (TAI), n (%)f | ||||
Good | 2767 (61.0) | 850 (68.1) | 1917 (58.3) | < 0.0001 |
Intermediate | 887 (19.6) | 242 (19.4) | 645 (19.6) | |
Bad | 883 (19.5) | 157 (12.6) | 726 (22.1) | |